Granules Executive and Leadership Team

Kamal Mandan, the Chief Financial Officer at Granules, directs all fiscal planning and capital allocation strategies. Mandan oversees the financial health of the organization, ensuring that investments in pharmaceutical manufacturing infrastructure align with long-term growth objectives. By managing complex budgetary requirements across international markets, the Chief Financial Officer maintains rigorous oversight of cost structures and revenue streams. This leadership role involves constant collaboration with the board to optimize capital efficiency and mitigate fiscal risks associated with global supply chains. Kamal Mandan drives the financial reporting processes that support transparency and investor confidence. Through precise analysis of market trends, the Chief Financial Officer secures the necessary funding to scale production capabilities for API and finished dosage products. Ultimately, Mandan ensures that the financial foundation remains robust enough to support the aggressive expansion goals of the company within the competitive pharmaceutical landscape.

Mukesh Surana, the Global Chief Financial Officer at Granules, manages the international financial strategy and risk management frameworks. Surana oversees the consolidation of global financial data, ensuring that the company maintains fiscal discipline across all regional operations. By analyzing international market trends, the Global Chief Financial Officer drives the development of strategies that optimize currency management and tax efficiency. This leadership role involves collaborating with regional finance heads to ensure compliance with local regulations while maintaining global standards. Mukesh Surana executes capital investment plans that support the expansion of the company footprint in key international markets. Through the rigorous monitoring of financial performance, the Global Chief Financial Officer provides the insights necessary for sustainable growth. Ultimately, Surana ensures that the global financial structure remains stable and capable of supporting the ambitious goals of the company in the competitive pharmaceutical manufacturing sector.

Jai Velusamy, the Chief Operating Officer at Granules, manages the end-to-end manufacturing operations for API and finished dosage products. Velusamy oversees the daily production workflows, ensuring that all facilities adhere to stringent quality control and safety regulations. By streamlining supply chain logistics, the Chief Operating Officer drives operational excellence across the entire manufacturing network. This leadership role involves coordinating with cross-functional teams to meet production targets while maintaining cost-effective output levels. Jai Velusamy executes strategic initiatives that enhance manufacturing capacity to satisfy growing global demand. Through the implementation of lean manufacturing principles, the Chief Operating Officer minimizes waste and maximizes throughput in every facility. Ultimately, Velusamy ensures that the operational backbone of the company remains agile and responsive to market fluctuations, thereby sustaining the reputation for reliability and quality that defines the organization within the pharmaceutical industry.

Vinod Parur, the President & Chief Human Resources Officer at Granules, directs the global talent strategy and organizational culture initiatives. Parur oversees the recruitment, development, and retention of a highly skilled workforce capable of meeting the demands of the pharmaceutical sector. By fostering an environment of continuous learning and professional growth, the President & Chief Human Resources Officer drives employee engagement and productivity. This leadership role involves designing compensation and benefits structures that attract top-tier talent in a competitive market. Vinod Parur executes workforce planning strategies that support the expansion of manufacturing operations across diverse geographic regions. Through the implementation of robust performance management systems, the President & Chief Human Resources Officer ensures that every team member contributes effectively to the company mission. Ultimately, Parur builds a resilient organizational culture that empowers the workforce to deliver excellence in every aspect of pharmaceutical product development and manufacturing.

Ramraj Rangarajalu, the President, Formulation Operations (India) at Granules, directs the manufacturing of finished dosage products within the domestic market. Rangarajalu oversees the production facilities, ensuring that all operations meet the highest quality standards for pharmaceutical formulations. By optimizing the manufacturing processes, the President, Formulation Operations (India) drives efficiency and reduces production costs. This leadership role involves managing the workforce and technical teams responsible for the daily output of essential medicines. Ramraj Rangarajalu executes strategies that increase production capacity to meet the rising demand for high-quality formulations. Through the implementation of rigorous quality assurance protocols, the President, Formulation Operations (India) ensures that every product meets regulatory requirements. Ultimately, Rangarajalu maintains the operational excellence of the Indian manufacturing base, ensuring that the company continues to provide reliable and affordable pharmaceutical solutions to the market while upholding the highest standards of safety and efficacy.

Vijay Raghavan, the Global President, Portfolio at Granules, directs the development and management of the entire product pipeline. Raghavan oversees the selection and prioritization of API and specialty products to ensure alignment with market needs and company growth targets. By analyzing global pharmaceutical trends, the Global President, Portfolio drives the innovation strategy that keeps the product offerings competitive. This leadership role involves collaborating with research and development teams to bring new formulations to market efficiently. Vijay Raghavan executes the lifecycle management of existing products, ensuring that the portfolio remains profitable and relevant. Through the strategic assessment of market opportunities, the Global President, Portfolio identifies areas for expansion and diversification. Ultimately, Raghavan shapes the future of the company by curating a robust and high-value product portfolio that addresses the evolving health needs of customers worldwide while maintaining a strong market position.

Srinivas Pv, the Chief Technology Officer at Granules, architects the digital transformation of pharmaceutical manufacturing processes. Pv oversees the integration of advanced automation and data analytics to enhance production efficiency across all facilities. By implementing cutting-edge technology solutions, the Chief Technology Officer ensures that the company maintains a competitive edge in API and specialty product development. This leadership role involves managing the cybersecurity framework and digital infrastructure that protect proprietary research and development data. Srinivas Pv drives the adoption of smart manufacturing initiatives that reduce operational downtime and improve product quality standards. Through the deployment of scalable software systems, the Chief Technology Officer enables seamless communication between global manufacturing sites. Ultimately, Pv optimizes the technological ecosystem to support the company mission of delivering high-quality pharmaceutical solutions through innovation and precision engineering in every aspect of the production cycle.

Sriram Chavali, the EA-Chief of Staff, Directorate at Granules, coordinates strategic initiatives between the executive leadership and the board. Chavali oversees the execution of corporate priorities, ensuring that departmental goals align with the overarching mission of the company. By facilitating communication across the directorate, the EA-Chief of Staff, Directorate drives organizational efficiency and clarity in decision-making processes. This leadership role involves managing high-level projects that impact the long-term trajectory of the pharmaceutical business. Sriram Chavali monitors the progress of key performance indicators to ensure that the company meets its growth targets. Through the synthesis of complex information, the EA-Chief of Staff, Directorate provides the necessary insights for the leadership team to navigate market challenges effectively. Ultimately, Chavali maintains the operational rhythm of the directorate, ensuring that all strategic efforts remain focused on achieving sustainable success and maintaining the company position as a leader in pharmaceutical manufacturing.

Vijay Kandpal, the Chief of Staff to Chairman & Managing Director at Granules, manages the strategic agenda for the executive office. Kandpal oversees the flow of information and priorities between the Chairman and the broader leadership team. By ensuring that the vision of the Chairman translates into actionable business plans, the Chief of Staff to Chairman & Managing Director drives organizational alignment. This leadership role involves preparing for high-stakes meetings and managing external stakeholder relationships that are critical to the company success. Vijay Kandpal monitors the execution of major corporate initiatives to ensure that the company remains on track with its long-term objectives. Through the coordination of cross-departmental efforts, the Chief of Staff to Chairman & Managing Director facilitates rapid decision-making. Ultimately, Kandpal supports the leadership in maintaining a clear focus on the core mission of delivering high-quality pharmaceutical products to global markets.